Doctor profile · Federal record
Dr. Meredith Reimer, M.D
Dermatology Physician (CMS: Dermatology) · Beachwood, OH
- NPI 1629273909
- Accepts Medicare
- 23 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3700 Park East Dr Ste 220
Beachwood, OH 441224339
(216) 678-9810
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- January 30, 2026
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Ohio #35.121291
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1629273909. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,688
Distinct HCPCS
10
Medicare allowed
$158,769
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 834 | 153 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 445 | 311 | $86 | |
17110 |
Destruction of skin growth, 1-14 growths | 276 | 216 | $102 | |
17000 |
Destruction of precancer skin growth, 1 growth | 266 | 209 | $48 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 185 | 185 | $106 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 148 | 113 | $122 | |
11102 |
Biopsy of related skin growth, first growth | 105 | 93 | $83 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 85 | 73 | $54 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 77 | 37 | $1 | |
11900 |
Injection into skin growth, 1-7 growths | 64 | 36 | $45 |
In context: peer comparison
Among 3 peers in Beachwood Dermatology Physician, average services per provider: 145. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$2,549
Transactions
102
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, INC. | 10 | $328.54 | |
| Janssen Biotech, INC. | 14 | $290.41 | |
| Journey Medical Corporation | 2 | $241.69 | |
| Abbvie INC. | 16 | $239.43 | |
| Ucb, INC. | 8 | $206.09 | |
| Genzyme Corporation | 12 | $192.23 | |
| Sun Pharmaceutical Industries INC. | 8 | $145.37 | |
| Novartis Pharmaceuticals Corporation | 5 | $136.30 | |
| Lilly USA, LLC | 5 | $108.03 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $105.83 | |
| Amgen INC. | 5 | $97.47 | |
| Regeneron Healthcare Solutions, INC. | 4 | $84.87 | |
| Galderma Laboratories, L.P. | 4 | $79.42 | |
| Incyte Corporation | 3 | $77.89 | |
| Leo Pharma INC. | 2 | $63.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
815
Patients
512
Total drug cost
$128,807
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 205 | 142 | $2,055 |
| Clobetasol Propionate | Generic | 140 | 83 | $8,252 |
| Ketoconazole | Generic | 97 | 53 | $1,774 |
| Hydrocortisone | Generic | 96 | 80 | $563 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 70 | 39 | $2,886 |
| Mupirocin | Generic | 41 | 32 | $373 |
| Metronidazole | Generic | 36 | 26 | $2,747 |
| Fluorouracil | Generic | 35 | 32 | $3,774 |
| Doxycycline Monohydrate | Generic | 29 | 0 | $994 |
| Otezla (Apremilast) | Brand | 21 | 0 | $103,789 |
Frequently asked questions
What is Dr. Meredith Reimer's medical specialty?
Dr. Meredith Reimer practices Dermatology Physician in Beachwood, OH.
Where does Dr. Meredith Reimer practice?
Dr. Meredith Reimer practices at 3700 Park East Dr Ste 220, Beachwood, OH 441224339. Office phone: 2166789810.
What is Dr. Meredith Reimer's NPI?
Dr. Meredith Reimer's National Provider Identifier (NPI) is 1629273909, issued by NPPES.
Does Dr. Meredith Reimer accept Medicare assignment?
Yes. Dr. Meredith Reimer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Meredith Reimer commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.